Skip to main content
Industry News
Brain tumor gene therapy nabs rare pediatric disease tag

The FDA awarded rare pediatric disease designation to Ziopharm Oncology's investigational gene therapy veledimex (Controlled IL-12) with Ad-RTS-hIL-12, a treatment for diffuse intrinsic pontine glioma, a type of brain tumor that accounts for about 10% to 15% of all brain tumors in children.

Full Story: